The Hartung Lab focuses on genetic kidney diseases, particularly autosomal recessive polycystic kidney disease (ARPKD). Research interests in the lab include developing new kidney and liver imaging biomarkers for ARPKD and other kidney diseases, including kidney transplant, using magnetic resonance imaging, and ultrasound. This work involves close collaborations with the Departments of Radiology at both CHOP and the University of Pennsylvania.
The Hartung Lab also investigates the natural history and clinical complications of ARPKD, and Erum A. Hartung, MD, MTR, serves as the site principal investigator for the first ever clinical trial of a disease-modifying therapy for ARPKD. In addition, the lab studies neurocognitive outcomes in children with kidney disease.
Assistant Professor of Pediatrics; Attending Physician, Division of Nephrology
Dr. Hartung's clinical and translational research program focuses on autosomal recessive polycystic kidney disease and other genetic kidney diseases, development of new kidney and liver imaging biomarkers, and neurocognitive outcomes in children with chronic kidney disease.